학술논문
HSD55 Non-Interventional, Real-World Study of Patients with Early Stage, Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Receiving Biosimilar Trastuzumab
Document Type
Abstract
Author
Source
In Value in Health July 2022 25(7) Supplement:S489-S489
Subject
Language
ISSN
1098-3015